HUGE.CN - FSD Pharma Inc.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2017-08-30
2016-08-30
Total Revenue
56
89
26
0
0
Cost of Revenue
-
-
-
-
-
Gross Profit
-
-
-
-
-
Operating Expenses
Research Development
-
-
-
-
-
Selling General and Administrative
24,574
24,779
3,550
24
39
Total Operating Expenses
32,427
32,462
3,550
24
39
Operating Income or Loss
-32,370
-32,373
-3,525
-24
-39
Interest Expense
-
-
-
-
-
Total Other Income/Expenses Net
-1,206
9,663
-
-
-
Income Before Tax
-33,584
-22,711
-3,525
-24
-39
Income Tax Expense
-
-
-
-
-
Income from Continuing Operations
-33,584
-22,711
-3,525
-24
-39
Net Income
-33,584
-22,711
-3,525
-24
-39
Net Income available to common shareholders
-33,584
-22,711
-3,525
-24
-39
Reported EPS
Basic
-
-0.02
-0.00
-0.00
-0.00
Diluted
-
-0.02
-0.00
-0.00
-0.00
Weighted average shares outstanding
Basic
-
1,186,941
1,319,615
1,319,615
1,319,615
Diluted
-
1,186,941
1,319,615
1,319,615
1,319,615
EBITDA
-
-32,190
-3,525
-24
-39